Implant surface treatment using biomimetic agents

Implant Dentistry

Volumn 18, Issue 1, 2009, Pages 17-26

  Avila, Gustavo ^a   Misch, Kelly ^a   Galindo Moreno, Pablo ^b   Wang, Hom Lay ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Bone formation; Dental implant; Osseointegration; Surface modification; Titanium

Indexed keywords

ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; BIOMATERIAL; BIOMEDICAL AND DENTAL MATERIALS; BIOMIMETIC MATERIAL; BONE MORPHOGENETIC PROTEIN; CHITOSAN; COLLAGEN TYPE 1; FLUORIDE; OLIGOPEPTIDE; SIGNAL PEPTIDE;

ARTICLE; BONE REGENERATION; CERAMICS; CHEMISTRY; HUMAN; PHYSIOLOGY; SURFACE PROPERTY; TOOTH IMPLANTATION;

BIOMIMETIC MATERIALS; BONE MORPHOGENETIC PROTEINS; CERAMICS; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; COLLAGEN TYPE I; DENTAL IMPLANTS; DENTAL MATERIALS; FLUORIDES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OLIGOPEPTIDES; OSSEOINTEGRATION; SURFACE PROPERTIES;

EID: 61649109315     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/ID.0b013e318192cb7d     Document Type: Article

References (69)

1. Branemark PI, Adell R, Breine U, et al. Intra-osseous anchorage of dental prostheses. I. Experimental studies. Scand J Plast Reconstr Surg. 1969;3:81-100.
2. Misch CE, Perel ML, Wang HL, et al. Implant success, survival, and failure: The International Congress of Oral Implantologists (ICOI) Pisa Consensus Conference. Implant Dent. 2008;17:5-15.
3. Huang LH, Shotwell JL, Wang HL. Dental implants for orthodontic anchorage. Am J Orthod Dentofacial Orthop. 2005;127:713-722.
4. Sohn DS, Lee JK, An KM. Minor tooth movements using microimplant anchorage: Case reports. Implant Dent. 2008;17:32-39.
5. Kato H, Nakamura T, Nishiguchi S, et al. Bonding of alkali- and heat-treated tantalum implants to bone. J Biomed Mater Res. 2000;53:28-35.
6. Johansson CB, Albrektsson T. A removal torque and histomorphometric study of commercially pure niobium and titanium implants in rabbit bone. Clin Oral Implants Res. 1991;2:24-29.
7. Peterson LJ, McKinney RV Jr, Pennel BM, et al. Clinical, radiographic, and histological evaluation of porous rooted cobalt-chromium alloy dental implants. J Dent Res. 1980;59:99-108.
8. Ducheyne P. Bioactive ceramics. J Bone Joint Surg Br. 1994;76:861-862.
9. Piattelli A, Podda G, Scarano A. Histological evaluation of bone reactions to aluminium oxide dental implants in man: A case report. Biomaterials. 1996;17:711-714.
10. Boyan BD, Schwartz Z. Modulation of osteogenesis via implant surface design. In: Davies JE, ed. Bone Engineering. Toronto: em squared Inc; 2000:232-239.
11. Gross UM. Biocompatibility: The interaction of biomaterials and host response. Int J Oral Implantol. 1988;5:37-38.
12. Schenk RK, Buser D. Osseointegration: A reality. Periodontol 2000. 1998;17:22-35.
13. Davies JE, Hosseini MM. Histodynamics of endosseous wound healing. In: Davies JE, ed. Bone Engineering. Toronto: em squared Inc; 2000:3.
14. Simon Z, Watson PA. Biomimetic dental implants - New ways to enhance osseointegration. J Can Dent Assoc. 2002;68:286-288.
15. de Groot K. Bioceramics consisting of calcium phosphate salts. Biomaterials. 1980;1:47-50.
16. Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials. 2003;24:4353-4364.
17. Jalbout Z, Tabourian G, eds. Glossary of Implant Dentistry II. New Jersey: International Congress of Oral Implantologists; 2008:18.
18. Golec TS, Krauser JT. Long-term retrospective studies on hydroxyapatite coated endosteal and subperiosteal implants. Dent Clin North Am. 1992;36:39-65.
19. Ogilvie A, Frank RM, Benque EP, et al. The biocompatibility of hydroxyapatite implanted in the human periodontium. J Periodontal Res. 1987;22:270-283.
20. Geesink RG, de Groot K, Klein CP. Chemical implant fixation using hydroxylapatite coatings. The development of a human total hip prosthesis for chemical fixation to bone using hydroxyl-apatite coatings on titanium substrates. Clin Orthop Relat Res. 1987;225:147-170.
21. Meffert RM. Ceramic-coated implant systems. Adv Dent Res. 1999;13:170-172.
22. Ducheyne P, Van Raemdonck W, Heughebaert JC, et al. Structural analysis of hydroxyapatite coatings on titanium. Biomaterials. 1986;7:97-103.
23. Oonishi H, Yamamoto M, Ishimaru H, et al. The effect of hydroxyapatite coating on bone growth into porous titanium alloy implants. J Bone Joint Surg Br. 1989;71:213-216.
24. Liu Y, de Groot K, Hunziker EB. Osteoinductive implants: The mise-enscene for drug-bearing biomimetic coatings. Ann Biomed Eng. 2004;32:398-406.
25. Wilke A, Traub F, Kienapfel H, et al. Cell differentiation under the influence of rh-BMP-2. Biochem Biophys Res Commun. 2001;284:1093-1097.
26. Badr NA, El Hadary AA. Hydroxyapatite-electroplated cp-titanium implant and its bone integration potential-ity: An in vivo study. Implant Dent. 2007;16:297-308.
27. Zagury R, Harari ND, Conz MB, et al. Histomorphometric analyses of bone interface with titanium-aluminum-vanadium and hydroxyapatite-coated implants by biomimetic process. Implant Dent. 2007;16:290-296.
28. Block MS, Kent JN. Cylindrical HA-coated implants-8-year observations. Compend Suppl. 1993:5526-3532; quiz S565-S566.
29. Guttenberg SA. Longitudinal report on hydroxyapatite-coated implants and advanced surgical techniques in a private practice. Compend Suppl. 1993:3549-S553; quiz S565-S566.
30. Stultz ER, Lofland R, Sendax VI, et al. A multicenter 5-year retrospective survival analysis of 6,200 integral implants. Compendium. 1993;14:478, 480, 482 passim.
31. Johnson BWH. A-coated dental implants: Long-term consequences. J Calif Dent Assoc. 1992;20:33-41.
32. Lee JJ, Rouhfar L, Beirne OR. Survival of hydroxyapatite-coated implants: A meta-analytic review. J Oral Maxillofac Surg. 2000;58:1372-1379; discussion 1379-1380.
33. Gottlander M, Albrektsson T. Histomorphometric analyses of hydroxyapatite-coated and uncoated titanium implants. The importance of the implant design. Clin Oral Implants Res. 1992;3:71-76.
34. Quirynen M, van der Mei HC, Bollen CM, et al. An in vivo study of the influence of the surface roughness of implants on the microbiology of supra- and subgingival plaque. J Dent Res. 1993;72:1304-1309.
35. Meffert RM. How to treat ailing and failing implants. Implant Dent. 1992;1:25-33.
36. Oosterbos CJ, Vogely H, Nijhof MW, et al. Osseointegration of hydroxyapatite-coated and noncoated 7i6AI4V implants in the presence of local infection: A comparative histomorphometrical study in rabbits. J Biomed Mater Res. 2002;60:339-347.
37. Ripamonti U, Reddi AH. Growth and morphogenetic factors in bone induction: Role of osteogenin and related bone morphogenetic proteins in craniofacial and periodontal bone repair. Crit Rev Oral Biol Med. 1992;3:1-14.
38. Puleo DA, Kissling RA, Sheu MS. A technique to immobilize bioactive proteins, including bone morphogenetic protein-4 (BMP-4), on titanium alloy. Biomaterials. 2002;23:2079-2087.
39. Christiansen JH, Coles EG, Wilkinson DG. Molecular control of neural crest formation, migration and differentiation. Curr Opin Cell Biol. 2000;12:719-724.
40. Urist MR, DeLange RJ, Finerman GA. Bone cell differentiation and growth factors. Science. 1983;220:680-686.
41. Boyne PJ. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. J Bone Joint Surg Am. 2001;83(suppl 1):S146-S150.
42. Wikesjo UM, Sorensen RG, Wozney JM. Augmentation of alveolar bone and dental implant Osseointegration: Clinical implications of studies with rhBMP-2. J Bone Joint Surg Am. 2001;83(suppl 1):S136-S145.
43. Tatakis DN, Koh A, Jin L, et al. Periimplant bone regeneration using recombinant human bone morphogenetic protein-2 in a canine model: A dose-response study. J Periodontal Res. 2002;37:93-100.
44. Thomson AW, Lotze M. The Cytokine Handbook. Avon: Academic Press; 2003.
45. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638-646.
46. Mazor Z, Peleg M, Garg AK, et al. Platelet-rich plasma for bone graft enhancement in sinus floor augmentation with simultaneous implant placement: Patient series study. Implant Dent. 2004;13:65-72.
47. Freymiller EG, Aghaloo TL. Platelet-rich plasma: Ready or not? J Oral Maxillofac Surg. 2004;62:484-488.
48. Giannobile WV. Periodontal tissue engineering by growth factors. Bone. 1996;19:23S-37S.
49. Geissler U, Hempel U, Wolf C, et al. Collagen type I-coating of Ti6AI4V promotes adhesion of osteoblasts. J Biomed Mater Res. 2000;51:752-760.
50. Morra M, Cassinelli C, Meda L, et al. Surface analysis and effects on interfacial bone microhardness of collagen-coated titanium implants: A rabbit model. Int J Oral Maxillofac Implants. 2005;20:23-30.
51. Kim HW, Li LH, Lee EJ, et al. Fibrillar assembly and stability of collagen coating on titanium for improved osteoblast responses. J Biomed Mater Res A. 2005;75:629-638.
52. Grzesik WJ, Robey PG. Bone matrix RGD glycoproteins: Immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res. 1994;9:487-496.
53. Rezania A, Healy KE. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J Orthop Res. 1999;17:615-623.
54. Roessler S, Born R, Scharnweber D, et al. Biomimetic coatings functionalized with adhesion peptides for dental implants. J Mater Sci Mater Med. 2001;12:871-877.
55. Ferris DM, Moodie GD, Dimond PM, et al. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials. 1999;20:2323-2331.
56. Kroese-Deutman HC, van den Dolder J, Spauwen PH, et al. Influence of RGD-loaded titanium implants on bone formation in vivo. Tissue Eng. 2005;11:1867-1875.
57. Senyah N, Hildebrand G, Liefeith K. Comparison between RGD-peptide-modified titanium and borosilicate surfaces. Anal Bioanal Chem. 2005;383:758-762.
58. Schliephake H, Scharnweber D, Dard M, et al. Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest. An experimental pilot study in dogs. Clin Oral Implants Res. 2002;13:312-319.
59. 2 gritblasted c.p. titanium endosseous implants. Biomaterials. 2006;27:926-936.
60. Caverzasio J, Palmer G, Bonjour JP. Fluoride: Mode of action. Bone. 1998;22:585-589.
61. Parley JR, Wergedal JE, Baylink DJ. Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells. Science. 1983;222:330-332.
62. Hall BK. Sodium fluoride as an initiator of osteogenesis from embryonic mesenchyme in vitro. Bone. 1987;8:111-116.
63. Modrowski D, Miravet L, Feuga M, et al. Effect of fluoride on bone and bone cells in ovariectomized rats. J Bone Miner Res. 1992;7:961-969.
64. Ellingsen JE, Johansson CB, Wennerberg A, et al. Improved retention and bone-to-implant contact with fluoride-modified titanium implants. Int J Oral Maxillofac Implants. 2004;19:659-666.
65. Singla AK, Chawla M. Chitosan: Some pharmaceutical and biological aspects - An update. J Pharm Pharmacol. 2001;53:1047-1067.
66. Bumgardner JD, Chesnutt BM, Yuan Y, et al. The integration of chitosan-coated titanium in bone: An in vivo study in rabbits. Implant Dent. 2007;16:66-79.
67. Ueno H, Yamada H, Tanaka I, et al. Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials. 1999;20:1407-1414.
68. Lahiji A, Sohrabi A, Hungerford DS, et al. Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res. 2000;51:586-595.
69. Cai K, Rechtenbach A, Hao J, et al. Polysaccharide-protein surface modification of titanium via a layer-by-layer technique: Characterization and cell behaviour aspects. Biomaterials. 2005;26:5960-5971.